Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Breier

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|October 6, 2005
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaRichard S E Keefe, Carrie A Young, Stephanie L Rock, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Early Intervention in Psychiatry|March 31, 2018
Internalized stigma in adults with early phase versus prolonged psychosisRuth L Firmin, Paul H Lysaker, Lauren Luther, et al.
The Journal of Clinical Psychiatry|March 28, 2009
A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophreniaJohn M Kane, Olawale Osuntokun, Ludmila A Kryzhanovskaya, et al.
The Journal of Clinical Psychiatry|December 22, 2009
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depressionRoy H Perlis, David H Adams, Bonnie Fijal, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placeboMargaret O Sowell, Nitai Mukhopadhyay, Patrizia Cavazzoni, et al.
The Journal of Clinical Psychiatry|July 15, 2005
Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychoticsMaurício Silva de Lima, Jair de Jesus Mari, Alan Breier, et al.
Schizophrenia Research|June 12, 2012
Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot studyOlga Rass, Jennifer K Forsyth, Amanda R Bolbecker, et al.
Schizophrenia Research|February 11, 2020
Functional network connectivity in early-stage schizophreniaTom A Hummer, Matthew G Yung, Joaquín Goñi, et al.
Journal of Affective Disorders|July 10, 2002
Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trialMadhav A Namjoshi, Gopalan Rajamannar, Thomas Jacobs, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|October 6, 2005
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaRichard S E Keefe, Carrie A Young, Stephanie L Rock, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Early Intervention in Psychiatry|March 31, 2018
Internalized stigma in adults with early phase versus prolonged psychosisRuth L Firmin, Paul H Lysaker, Lauren Luther, et al.
The Journal of Clinical Psychiatry|March 28, 2009
A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophreniaJohn M Kane, Olawale Osuntokun, Ludmila A Kryzhanovskaya, et al.
The Journal of Clinical Psychiatry|December 22, 2009
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depressionRoy H Perlis, David H Adams, Bonnie Fijal, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placeboMargaret O Sowell, Nitai Mukhopadhyay, Patrizia Cavazzoni, et al.
The Journal of Clinical Psychiatry|July 15, 2005
Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychoticsMaurício Silva de Lima, Jair de Jesus Mari, Alan Breier, et al.
Schizophrenia Research|June 12, 2012
Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot studyOlga Rass, Jennifer K Forsyth, Amanda R Bolbecker, et al.
Schizophrenia Research|February 11, 2020
Functional network connectivity in early-stage schizophreniaTom A Hummer, Matthew G Yung, Joaquín Goñi, et al.
Journal of Affective Disorders|July 10, 2002
Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trialMadhav A Namjoshi, Gopalan Rajamannar, Thomas Jacobs, et al.
Pageof 11